Amitriptyline and Triptorelin: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Amitriptyline
Triptorelin
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
You've been prescribed two medicines that can each affect your heart's rhythm. Amitriptyline (Elavil) is an older antidepressant, and triptorelin is a hormone therapy. Both can slightly stretch out part of your heartbeat called the QT interval. When taken together, that effect can add up and, in rare cases, lead to an irregular heartbeat.
Right now this is a theoretical concern rather than something proven, so try not to worry. The good news is that your care team can manage it easily by checking your heart rhythm and blood minerals when needed. Keep taking both exactly as prescribed and let your doctor or pharmacist know if you feel dizzy, faint, or notice a racing heart.
Additive QT prolongation (pharmacodynamic interaction, not metabolic). Amitriptyline is a known QT-prolonging TCA; triptorelin, a GnRH agonist, may prolong QT via androgen deprivation. Effect is additive; direction increases arrhythmia (torsades) risk. Neither is a prodrug in this context.
- Evidence: theoretical; severity: major; onset: unspecified.
- Management: weigh benefit of ADT vs risk, especially with congenital long QT, CHF, or electrolyte disturbances. Avoid combination when possible.
- If coadministered, avoid drugs causing hypokalemia/hypomagnesemia, correct electrolyte abnormalities, and consider periodic ECG and electrolyte monitoring.
What happens
Increased risk of QT interval prolongation
Interaction Deep Dive
When triptorelin is given together with medications that prolong the QT interval, the effects on the QT interval are additive. GnRH agonists and antagonists can lengthen the QT interval through androgen deprivation. In patients who have congenital long QT syndrome, congestive heart failure, or recurrent electrolyte disturbances, as well as in those receiving drugs recognized to prolong the QT interval, clinicians should weigh whether the advantages of androgen deprivation therapy such as triptorelin justify the possible risks1. Where feasible, refrain from using triptorelin alongside agents that prolong the QT interval. Should coadministration be necessary, steer clear of drugs that produce electrolyte disturbances (that is, hypokalemia or hypomagnesemia)2, correct any electrolyte abnormalities, and consider periodic monitoring of ECGs and electrolytes1.
Why it happens (mechanism)
Additive QT interval prolongation
How to manage this interaction
Both drugs can lengthen the QT interval, so your care team will decide whether the benefit of triptorelin outweighs the risk, particularly if you have a heart condition, congestive heart failure, or a history of low potassium or magnesium.
- Keep taking both as prescribed unless your doctor tells you otherwise.
- Your team may order periodic ECGs and blood tests to check potassium and magnesium, and correct any imbalances.
- Ask before starting other medicines that affect heart rhythm or minerals.
Tell your pharmacist or prescriber right away if you feel faint, dizzy, or notice a fluttering or racing heartbeat.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) In an analysis of male patients undergoing androgen deprivation therapy (ADT) using individual case safety reports from VigiBase, the international pharmacovigilance database, investigators identified 184 cases of acquired long-QT syndrome (aLQTS) and/or torsades de pointes (TdP; 11% of which were fatal), along with 99 cases of sudden death linked to ADT. The majority of aLQTS/TdP cases (62%) and sudden death cases (88%) tied to ADT arose without concurrent use of other agents recognized to raise TdP risk; nevertheless, use of 1 drug and use of 2 or more drugs with conditional, possible, or known TdP risk was documented in a portion of aLQTS/TdP (23% or 43%) and sudden death (18% and 22%) events. The agents classified as ADTs included abiraterone, gonadotropin-releasing hormone agonists and antagonists, nonsteroidal androgen receptor inhibitors indicated for prostate cancer, and 5-alpha-reductase inhibitors indicated for androgenic alopecia and prostatism. Among the 10 ADTs assessed, 7 showed a disproportional association (reporting odds ratio, 1.4 to 4.7) with aLQTS, TdP, or sudden death, namely leuprorelin, goserelin, triptorelin, degarelix, bicalutamide, finasteride, and dutasteride. The patients had a median age of roughly 76 years, and the median time to onset was 170 days (range, 7 to 4884 days) for aLQTS/TdP events and 92 days (range, 0.25 to 4984 days) for sudden death events. Patients were principally taking ADT for prostate cancer, with some treated for prostatism and androgenic alopecia. Most patients were on ADT monotherapy (83%); 17% were receiving ADT combination therapy 3.
Common questions
Can I take Amitriptyline and Triptorelin together?
Amitriptyline and triptorelin can each prolong the QT interval, so combining them may add up and raise arrhythmia risk. Keep taking both as prescribed and let your care team monitor your heart rhythm and electrolytes. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Amitriptyline and Triptorelin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Amitriptyline and Triptorelin interaction managed?
Both drugs can lengthen the QT interval, so your care team will decide whether the benefit of triptorelin outweighs the risk, particularly if you have a heart condition, congestive heart failure, or a history of low potassium or magnesium. Keep taking both as prescribed unless your doctor tells you otherwise. Your team may order periodic ECGs and blood tests to check potassium and magnesium, and c… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Amitriptyline or Triptorelin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (3)
- Product Information: TRELSTAR(R) intramuscular injection suspension, triptorelin pamoate intramuscular injection suspension. Verity Pharmaceuticals Inc (per FDA), Ewing, NJ, 2025.
- Lyon AR, Lopez-Fernandez T, Couch LS, et al: 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J 2022; 43(41):4229-4361.
- Salem JE, Yang T, Moslehi JJ, et al: Androgenic effects on ventricular repolarization: a translational study from the international pharmacovigilance database to iPSC-cardiomyocytes. Circulation 2019; 140(13):1070-1080. PubMed
Keep reading about Amitriptyline
Keep reading about Triptorelin
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist